Table 1.
n | % | ||
---|---|---|---|
Number of participants | 20 | ||
Gender | |||
female | 10 | (50.0) | |
male | 10 | (50.0) | |
ADHD subtype according to DSM-IV TR | |||
combined | 13 | (65.0) | |
hyperactive/impulsive | 6 | (30.0) | |
inattentive | 1 | (5.0) | |
Nicotine dependence according to Fagerström | |||
very low | 2 | (10.0) | |
low | 1 | (5.0) | |
moderate | 1 | (5.0) | |
high | 8 | (40.0) | |
very high | 8 | (40.0) | |
Medication at time of interview | |||
stimulants | 13 | (65.0) | |
antidepressants | 11 | (55.0) | |
mood stabilizers | 2 | (10.0) | |
antipsychotics | 2 | (10.0) | |
Previous phases of nicotine abstinencea | |||
none | 5 | (25.0) | |
<1 month | 5 | (25.0) | |
1 - 12 months | 6 | (30.0) | |
>1 year | 4 | (20.0) | |
Number of comorbid psychiatric diagnosis groups except for ADHD and nicotine dependence | |||
none | 2 | (10.0) | |
one | 10 | (50.0) | |
more than one | 8 | (40.0) | |
Comorbid psychiatric diagnosis groups except substance use disorders (ICD-10) | |||
schizophrenia | 1 | (2.4) | |
mood disorders | 3 | (15.0) | |
neurotic disorders | 4 | (20.0) | |
personality disorders | 3 | (15.0) |
aas of the time of interview, self reported, where possible chart verified